Abstract
Studies of area patterning of the neocortex have focused on primary areas, concluding that the primary visual area, V1, is specified by transcription factors (TFs) expressed by progenitors. Mechanisms that determine higher-order visual areas (VHO) and distinguish them from V1 are unknown. We demonstrated a requirement for thalamocortical axon (TCA) input by genetically deleting geniculocortical TCAs and showed that they drive differentiation of patterned gene expression that distinguishes V1 and VHO. Our findings suggest a multistage process for area patterning: TFs expressed by progenitors specify an occipital visual cortical field that differentiates into V1 and VHO; this latter phase requires geniculocortical TCA input to the nascent V1 that determines genetic distinctions between V1 and VHO for all layers and ultimately determines their area-specific functional properties.
The neocortex is patterned into functionally distinct fields that include primary sensory areas, which receive modality-specific sensory input from thalamocortical axons (TCAs) that originate from the principal sensory nuclei of the dorsal thalamus (dTh), and higher-order sensory areas that are connected with the primary areas through intracortical projections (1). Studies of mechanisms that pattern the neocortex into areas, known as arealization, have focused on primary areas and have led to the prevailing model that genetic mechanisms intrinsic to the neocortex are predominant in arealization (2). Transcription factors (TFs) expressed in neocortical progenitors determine the size and position of primary areas (2–5) and regulate guidance information that governs the area-specific targeting of TCAs (6). However, roles for TCAs in arealization remain vague (7–10), and important features of arealization, such as differential gene expression in the embryonic neocortex that relates to nascent areas, develop independently of TCA input (9, 10).
Higher-order areas outnumber primary areas by roughly 10-fold; for example, in mouse, nine higher-order visual areas (VHO) are positioned around the primary visual area (V1) within the occipital neocortex (11). However, mechanisms that specify and regulate differentiation of the particular properties of higher-order areas and distinguish them from primary areas have yet to be explored (11, 12). To perform genetic manipulations of dTh neurons required for these studies, we created RORα-IRES-Cre mice (RORαCre; fig. S1, A and B) with RORα function intact and expression of Cre recombinase driven by RORα regulatory elements (13). Crossing this RORαCre mouse to conditional reporter lines (fig. S1) revealed Cre-mediated recombination in neurons of the principal sensory nuclei in dTh at embryonic day 14.5 (E14.5), shortly after they become postmitotic (14), with robust recombination in the dorsal lateral geniculate nucleus (dLG) (fig. S1, C to K), which forms the geniculocortical TCA projection that relays visual information from the eyes selectively to V1. Little or no recombination was detected in the neocortex through the end of the first postnatal week, encompassing the differentiation of cortical areas and the time frame of our study (fig. S1, C to K).
We crossed RORαCre mice to mice in which the third exon of the COUP-TF1 gene is flanked by loxP sites, i.e. floxed (fl) COUP-TF1 [COUP-TF1fl/fl is described in (5)], because COUP-TF1 is strongly expressed in dLG, COUP-TF1 deletion diminishes axon growth (15), and most TCAs fail to reach the cortex in COUP-TF1–null mice (16). COUP-TF1–null mice are not useful for our studies because of viability issues and defects in cortical development (16). In contrast, the conditional knockout (cKO) mice (RORαCre/+ or RORαCre/Cre; COUP-TF1fl/fl) were viable and retained robust COUP-TF1 expression in the neocortex (fig. S2, A and B), but COUP-TF1 was deleted from dLG by E15.5 (fig. S2, A and B), and dLG size in cKO mice progressively decreased from the wild-type (WT) size embryonically to virtually absent by postnatal day 7 (P7) (figs. S2, C and D, and S3).
To visualize TCA projections in the cortex, we first used serotonin [5-hydroxytryptamine (5-HT)] immunostaining on tangential sections of flattened P7 cortices. In P7 WT mice, 5-HT staining revealed the geniculocortical TCA projection from dLG to V1, as well as TCA projections from the ventroposterior nucleus (VP) to the primary somatosensory area (S1) and from the medial geniculate nucleus (MG) to the primary auditory area (A1) (Fig. 1A). In P7 cKO mice, 5-HT staining showed that TCA projections to S1 and A1 were intact, but the geniculocortical TCA projection to V1 was absent (Fig. 1A). The loss of geniculocortical input to V1 in P7 cKO mice was confirmed by anterograde and retrograde axon tracing from dLG and V1 (fig. S4, A and B) and by crossing the cKO mice to a ROSA26-GAP43-eGFP reporter line that labels TCAs by RORαCre reporter activation (fig. S5A). Thus, conditional deletion of COUP-TF1 from dLG using the RORαCre line resulted in deletion of the geniculocortical TCA projection by P7, but COUP-TF1 remained intact in the cortex.
To determine the time course of the geniculo-cortical TCA projection in cKO mice as compared to WT mice, we bred RORαCre mice on either a WT (COUP-TF1fl/+; RORαCre/+) or cKO (COUP-TF1fl/fl; RORαCre/+ or COUP-TF1fl/fl; RORαCre/Cre) background, to a conditional reporter line (Ai14 tdTomato) (17). Activation of the tdTomato reporter with the RORαCre line labeled, at high resolution, geniculocortical TCAs from the dLG and TCAs from VP and MG projecting to S1 and A1 (Fig. 1B). Geniculocortical TCAs extend tangentially in the subplate and underlie the cortical plate (CP) of nascent V1 by E16.5, invade after birth the overlying V1 CP, and over the first postnatal week arborize in V1 layer 4, their predominant target layer (18). At E16.5, before TCAs invade the CP, the appearance of tdTomato-labeled TCAs was indistinguishable between WT and cKO mice, with a high density of labeled TCAs present in the occipital cortex of both (Fig. 1B). At P1, when geniculocortical TCAs normally invade the CP of V1, the density of labeled axons in the occipital cortex was substantially decreased in cKO mice as compared to WT mice (Fig. 1B). By P3, labeled geniculocortical TCAs were robustly arborizing in layer 4 of V1 of WT mice but were virtually absent from V1 and from the entire occipital cortex of cKO mice (Fig. 1B). These findings were corroborated by retrograde axon tracing from V1 and S1 (figs. S4 and S6). Thus, geniculo-cortical TCAs appeared WT in embryonic cKO mice but were eliminated early postnatally before significantly invading the CP or arborizing in layer 4 of V1.
Retrograde labeling from V1 and S1 showed that the area specificity of TCA input in the cKO mice was similar to that in the WT mice (19, 20) (figs. S4 and S6). Overall size, surface area, and tangential dimensions of the cortex were also similar between WT and cKO mice, as was S1 position in the cortex and occipital cortex size, which in WT mice is primarily V1 and VHO (fig. S5). Other features of the occipital cortex, including thickness, cell density, and lamination, had similar appearances in adult cKO and WT mice (fig. S7). Thus, mechanisms intrinsic to the cortex determine the overall size of the occipital visual cortical field and of S1 relative to it, independent of geniculocortical TCA input.
This cKO line provided a model to address whether geniculocortical TCA input to V1 differentiates the occipital visual cortical field into V1 and VHO and whether its early postnatal deletion disturbs this patterning. The distinct properties and functions that distinguish V1 from VHO are largely determined by their genetic profiles; i.e., differences in their patterned expression of sets of genes. Therefore, we developed gene markers that distinguished V1 and VHO and were exemplary of their distinct genetic profiles. We assessed in WT mice when area patterning is mature, at P7 and later, the expression of candidate genes to identify those that marked V1 or VHO in patterns that distinguished them and fully delineated one or the other, or both uniquely, using tangential sections of flattened cortices and cortical whole mounts, augmented with sagittal sections to also assess laminar expression. The majority of genes expressed in visual areas did not delineate nor distinguish V1 and/or VHO, but we identified a set of genes that did, and by definition they are among those that generate the distinct properties that define and distinguish V1 and VHO (21–27).
Figure 2A illustrates the two types of expression patterns that delineated V1 and 5-HT staining to mark geniculocortical TCAs terminating in layer 4 of V1. In P7 WT mice, RORβ was highly expressed in V1 layer-4 neurons but at low levels in VHO, whereas in P14 WT mice, Igfbp4 expression was not detected in V1 but was robust in layers 2/3 of VHO. The relationship of these expression patterns to geniculocortical TCA input to V1 suggests that this input induces the patterned expression of genes such as RORβ and represses the patterned expression of genes such as Igfbp4. In P7 cKO mice, coincident with loss of geniculocortical TCA input to V1, RORβ expression exhibited a significant reduction in V1, complemented by a significant increase of RORβ expression in VHO, whereas Igfbp4 expression exhibited a strong up-regulation in V1 of P14 cKO mice (Fig. 2A). We performed densitometry of RORβ expression to quantify its areal expression in P7 WT and cKO mice (Fig. 2B). In P7 WT mice, V1 and S1 had similar high levels of RORβ expression and significantly lower expression in VHO, resulting in a trough in expression intensity coincident with VHO (Fig. 2C). In P7 cKO mice, S1 had high expression similar to that in WT mice, but the high expression in V1 and the low expression trough coincident with VHO were replaced by flattened RORβ expression across the occipital visual cortical field of VHO and V1. The absence in cKO mice of RORβ expression differences between VHO and V1 characteristic of WT mice was due to both increased expression in VHO and decreased expression in V1, and unlike WT mice, no significant difference was evident in expression levels between VHO and V1 in the cKO mice (Fig. 2C,D).
Gene markers in our panel suitable for whole-mount in situ hybridization (WMISH) at P7 delineated V1 and VHO in the intact brain, while retaining the natural shapes and positions of areas. In P7 WT cortices, moderate expression of Igfbp5 selectively marked the entire V1 and distinguished it from VHO, which had nondetectable levels of Igfbp5. In P7 cKO cortices, Igfbp5 expression in V1 was diminished to a level indistinguishable from that in VHO, and the entire occipital visual cortical field had low or nondetectable Igfbp5 expression. In P7 WT mice, both cadherin8 (Cad8) and Lmo4 showed opposing expression patterns as compared to Igfbp5, with higher expression in VHO than V1, in distinct patterns that fully delineated V1 and VHO independently. In cKO mice, the patterned expression of Cad8 and Lmo4 was lost, and neither distinguished VHO from V1; instead, the occipital visual cortical field exhibited a homogeneous expression across its full extent, due in large part to increased expression of both genes throughout V1 to a level equivalent to that in VHO (Fig. 3).
The expression of the type 2 muscarinic acetylcholine receptor (m2AChR) and distinct phosphorylation forms of neurofilaments (SMI-32) in adult WT mice delineate and distinguish V1 and VHO and contribute to their specific functional properties (11, 26, 27). Immunostaining for m2AChR revealed low or nondetectable labeling of VHO between the strongly labeled V1 and S1 (Fig. 4A). In adult cKO mice, immunostaining for m2AChR was substantially diminished in layer 4 throughout V1, coupled with significantly increased staining of layer 4 in VHO, resulting in homogeneous low staining across the entire occipital visual cortical field normally composed of V1 and VHO (Fig. 4B). In situ hybridization for m2AChR recapitulated both the WT and cKO expression patterns observed with m2AChR staining patterns (Fig. 4B), showing that the changes in the cKO mice reflected a reduction of m2AChR expression by V1 layer 4 neurons rather than the loss of presynaptic m2AChR protein (27). Immunostaining for SMI-32 in adult WT mice also delineated V1 from VHO with robust staining of V1 and low staining of VHO, but with staining predominantly localized to projection neurons in layers 3 and 5. Deletion of geniculo-cortical TCAs to V1 in the cKO mice produced a substantial reduction in SMI-32 staining of both layer-3 and -5 projection neurons in V1 of adult cKO mice as compared to WT mice, resulting in homogeneous staining of layers 3 and 5 across the occipital visual cortical field and an inability to distinguish V1 from VHO (Fig. 4, A and B).
We have shown a prominent role for TCA input and redefined the role of intrinsic genetic regulation of the differentiation of higher-order sensory areas from primary sensory areas (fig. S8A). We selectively deleted geniculocortical TCA input to V1 early in postnatal development to accomplish two goals: (i) to assess the requirement of geniculocortical TCA input for the differentiation of genetic profiles that distinguish V1 from VHO and establish their specific functional properties; and (ii) to isolate the function of intrinsic genetic mechanisms to assess their role relative to geniculocortical TCAs in the specification and differentiation of V1 and VHO. Isolating in cKO mice the function of intrinsic genetic mechanisms in patterning V1 and VHO redefined their roles in arealization and showed that they specify an occipital visual cortical field that has a similar genetic profile over its extent. Geniculocortical TCA input is required postnatally to differentiate the visual cortical field into V1 and VHO and establish the genetic profiles that delineate and distinguish them. Regardless of whether in WT mice the gene and protein markers were more highly expressed in V1 than VHO, or vice versa, they exhibited significant changes in their patterned expression in cKO mice in which geniculocortical TCA input was deleted, resulting in a uniform intermediate level of expression across the occipital visual cortical field that would normally differentiate into V1 and VHO (fig. S8B). The change from patterned to uniform expression occurred through bidirectional changes in expression, with both down-regulation of expression in V1 and up-regulation in VHO, or vice versa, to produce intermediate expression levels across the occipital visual cortical field despite the selective targeting in WT mice of geniculocortical TCAs to only part of the occipital visual cortical field; i.e., the nascent V1. These changes in patterned gene expression occurred not only in the primary TCA target layer 4, but also in layers 2, 3, and 5, which receive little or no direct TCA input.
Our findings require a revision of the prevailing model of arealization and indicate a working model with distinct stages: Intrinsic genetic mechanisms specify an occipital visual cortical field with a relatively uniform genetic profile, followed by its differentiation into V1 and VHO driven by geniculocortical TCA input targeted selectively to the nascent V1 (fig. S9). This multistage process of arealization creates the hierarchical cortical organization of primary and higher-order visual areas that is required for proper visual perception and behavior.
Supplementary Material
Acknowledgments
We thank members of the O’Leary lab for discussion, including S. May for developing Igfbp5 as a V1 marker using WMISH, and B. Higgins and H. Gutierrez for maintaining mice. We thank M. Goulding (Salk Institute) for the ROSA-GAP43-eGFP reporter line, K.-F. Lee (Salk Institute) for the IRES/Cre/FRT/neo/FRT construct, A. Nagy (Mount Sinai Hospital) for the R1 ES cells, J. Simon (Salk MultiMedia Relations) for help making Adobe Illustrator schematics, and C. Peto (Salk Institute Neuroscience Imaging Core) for help using ImageJ software. Support was provided by NIH R01 grants NS31558 and MH086147 and the Vincent J. Coates Chair of Molecular Neurobiology (D.D.M.O.). M.S. is supported by the ANR “2009 Chaires d’Excellence” Program, France, grant number R09125AA. Z.B. was a recipient of postdoctoral fellowships from the Spanish Ministry of Education and Science and from the Generalitat de Catalunya (Spain).
Footnotes
References and Notes
- 1.Felleman DJ, Van Essen DC. Cereb Cortex. 1991;1:1. doi: 10.1093/cercor/1.1.1-a. [DOI] [PubMed] [Google Scholar]
- 2.O’Leary DD, Chou SJ, Sahara S. Neuron. 2007;56:252. doi: 10.1016/j.neuron.2007.10.010. [DOI] [PubMed] [Google Scholar]
- 3.Bishop KM, Goudreau G, O’Leary DD. Science. 2000;288:344. doi: 10.1126/science.288.5464.344. [DOI] [PubMed] [Google Scholar]
- 4.Hamasaki T, Leingärtner A, Ringstedt T, O’Leary DD. Neuron. 2004;43:359. doi: 10.1016/j.neuron.2004.07.016. [DOI] [PubMed] [Google Scholar]
- 5.Armentano M, et al. Nat Neurosci. 2007;10:1277. doi: 10.1038/nn1958. [DOI] [PubMed] [Google Scholar]
- 6.Leingärtner A, Richards LJ, Dyck RH, Akazawa C, O’Leary DD. Cereb Cortex. 2003;13:648. doi: 10.1093/cercor/13.6.648. [DOI] [PubMed] [Google Scholar]
- 7.Rakic P, Suñer I, Williams RW. Proc Natl Acad Sci USA. 1991;88:2083. doi: 10.1073/pnas.88.6.2083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dehay C, Giroud P, Berland M, Killackey H, Kennedy H. J Comp Neurol. 1996;367:70. doi: 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
- 9.Miyashita-Lin EM, Hevner R, Wassarman KM, Martinez S, Rubenstein JL. Science. 1999;285:906. doi: 10.1126/science.285.5429.906. [DOI] [PubMed] [Google Scholar]
- 10.Nakagawa Y, Johnson JE, O’Leary DD. J Neurosci. 1999;19:10877. doi: 10.1523/JNEUROSCI.19-24-10877.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang Q, Burkhalter A. J Comp Neurol. 2007;502:339. doi: 10.1002/cne.21286. [DOI] [PubMed] [Google Scholar]
- 12.Marshel JH, Garrett ME, Nauhaus I, Callaway EM. Neuron. 2011;72:1040. doi: 10.1016/j.neuron.2011.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nakagawa Y, O’Leary DD. Dev Neurosci. 2003;25:234. doi: 10.1159/000072271. [DOI] [PubMed] [Google Scholar]
- 14.Lund RD, Mustari MJ. J Comp Neurol. 1977;173:289. doi: 10.1002/cne.901730206. [DOI] [PubMed] [Google Scholar]
- 15.Armentano M, Filosa A, Andolfi G, Studer M. Development. 2006;133:4151. doi: 10.1242/dev.02600. [DOI] [PubMed] [Google Scholar]
- 16.Zhou C, et al. Neuron. 1999;24:847. doi: 10.1016/s0896-6273(00)81032-6. [DOI] [PubMed] [Google Scholar]
- 17.Madisen L, et al. Nat Neurosci. 2010;13:133. doi: 10.1038/nn.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.López-Bendito G, Molnár Z. Nat Rev Neurosci. 2003;4:276. doi: 10.1038/nrn1075. [DOI] [PubMed] [Google Scholar]
- 19.Bilateral enucleation in marsupials, which leads to decreased dLG size because of loss of retinal input, results in aberrant TCA input to V1 from dTh nuclei that normally project exclusively to other primary areas (20). Despite the selective deletion of the geniculocortical TCA projection in cKO mice, DiI injections into the putative V1 of the cKO mice did not aberrantly label neurons in VP, MG, or elsewhere in dTh (figs. S4 and S6). Injections of a second, retrograde tracer, DiD, targeted to nascent S1 and distinguishable from DiI injected into nascent V1 of the same mice, labeled a similar-appearing high density of VP neurons in WT and cKO mice at both P0 and P7, and at late embryonic ages, but in neither WT nor cKO mice did S1 injections label neurons in dLG (figs. S4 and S6).
- 20.Karlen SJ, Kahn DM, Krubitzer L. Neuroscience. 2006;142:843. doi: 10.1016/j.neuroscience.2006.06.055. [DOI] [PubMed] [Google Scholar]
- 21.The marker genes identified that met our criteria included those encoding the TFs, Lmo4 and RORβ, and the cell adhesion molecule Cad8, all of which function in cortical development (10, 13, 22–24); insulin-like growth factor–binding proteins Igfbp4 and Igfbp5 (25); and m2AChR and neurofilament subunits with the nonphosphorylated epitope SMI-32 that contribute to functional distinctions between V1 and VHO (11, 26, 27). One subset of marker genes had more robust expression in V1 than VHO (RORβ, Igfbp5, m2AChR, and SMI-32) and the other in VHO than V1 (Igfbp4, Lmo4, and Cad8). Each clearly identified the border between V1 and VHO and was expressed more-or-less uniformly throughout either V1 or VHO.
- 22.Bulchand S, Subramanian L, Tole S. Dev Dyn. 2003;226:460. doi: 10.1002/dvdy.10235. [DOI] [PubMed] [Google Scholar]
- 23.Kashani AH, et al. J Neurosci. 2006;26:8398. doi: 10.1523/JNEUROSCI.0618-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Jabaudon D, Shnider SJ, Tischfield DJ, Galazo MJ, Macklis JD. Cereb Cortex. 2012;22:996. doi: 10.1093/cercor/bhr182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Firth SM, Baxter RC. Endocr Rev. 2002;23:824. doi: 10.1210/er.2001-0033. [DOI] [PubMed] [Google Scholar]
- 26.Van der Gucht E, Hof PR, Van Brussel L, Burnat K, Arckens L. Cereb Cortex. 2007;17:2805. doi: 10.1093/cercor/bhm012. [DOI] [PubMed] [Google Scholar]
- 27.van der Zee EA, Matsuyama T, Strosberg AD, Traber J, Luiten PGM. Histochemistry. 1989;92:475. doi: 10.1007/BF00524759. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.